Rituximab Monotherapy for Primary Cutaneous Follicle Center Lymphoma

Authors

  • Ajay Dhakal St. Joseph Regional Medical Center, Lewiston ID
  • David M Tretheway St. Joseph Regional Medical Center, Lewiston ID
  • Rebecca Fulton St. Joseph Regional Medical Center, Lewiston ID
  • Binay Kumar Shah St. Joseph Regional Medical Center, Lewiston ID

DOI:

https://doi.org/10.3126/jaim.v1i1.5834

Keywords:

PCFCL, rituximab, radiotherapy

Abstract

Primary cutaneous follicle center lymphoma is a rare disorder. Although there are several treatment options, large clinical trials on the treatment of primary cutaneous follicle center lymphoma are lacking. Optimal treatment of this disease is unclear. We describe a case of primary cutaneous follicle center lymphoma treated with systemic rituximab, and review the literature.

DOI: http://dx.doi.org/10.3126/jaim.v1i1.5834

Journal of Advances in Internal Medicine. 2012; 1(1): 16-18

Downloads

Download data is not yet available.
Abstract
987
PDF
435

Downloads

How to Cite

Dhakal, A., Tretheway, D. M., Fulton, R., & Shah, B. K. (2012). Rituximab Monotherapy for Primary Cutaneous Follicle Center Lymphoma. Journal of Advances in Internal Medicine, 1(1), 16–18. https://doi.org/10.3126/jaim.v1i1.5834

Issue

Section

Case Reports